From a clinical viewpoint, the presence of high Dll4 expression levels may be considered a risk factor for tumor progression; therefore, implementing a strict systemic therapeutic plan, such as immunotherapy, angiogenesis inhibitor drugs or chemotherapy, following surgery, along with regular investigation may improve prognosis. This evidence concerns the gene DLL4 and neoplasm.